Intratio
Loading...
Skip to main content
Stock comparison · Signal date 2026-11-06

CBIH vs FOXO: stock comparison and AI forecast

Cannabis Bioscience International Holdings, Inc. (CBIH) and Foxo Technologies Inc. (FOXO) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market

Share
OTC · Services-Commercial Physical & Biological Research

CBIH Cannabis Bioscience International Holdings, Inc.

Price
$0.00 -66.7% · 6M
Market Cap
n/a
P/E Ratio
–
AI Forecast
Full analysis →
OTC · Services-Commercial Physical & Biological Research

FOXO Foxo Technologies Inc.

Market Cap
$170K
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
Model output

Which one does the AI model favor?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

CBIH · FOXO

Key facts

  • Both companies share the SEC industry classification Services-Commercial Physical & Biological Research.
Fundamentals

Fundamentals side by side

Trailing twelve months.

Valuation & Market

MetricCBIHFOXO
Market Cap–$170K
EPS$0.00–

Profitability & Margins

MetricCBIHFOXO
ROA-31398.1%–
ROIC32.3%–
Gross Margin60.3%–
Operating Margin-379.5%–
Net Margin-467.9%–
EBT Margin-379.5%–
Tax Rate0.0%–

Financial Health

MetricCBIHFOXO
Current Ratio0.00x0.12x
Quick Ratio–0.11x
Interest Coverage-2.7x6.7x
Working Capital-$1M-$36M

Cash Flow

MetricCBIHFOXO
Operating Cash Flow-$280K-$5M

Income Statement

MetricCBIHFOXO
Operating Income-$390K$8M
Net Income-$480K–
R&D Expense–$180K
SG&A Expense–$11M
Cost of Goods Sold$40K–

Dividend & Shareholder Information

MetricCBIHFOXO
Shares Outstanding–2M
FAQ

CBIH vs FOXO: stock comparison and AI forecast

Which one does Intratio's AI model rank higher, CBIH or FOXO?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.